Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Total Debt (2016 - 2025)

Angiodynamics' Total Debt history spans 15 years, with the latest figure at $5.0 million for Q1 2025.

  • For Q1 2025, Total Debt fell 47.37% year-over-year to $5.0 million; the TTM value through Feb 2025 reached $5.0 million, down 47.37%, while the annual FY2024 figure was $4.7 million, 92.68% down from the prior year.
  • Total Debt reached $5.0 million in Q1 2025 per ANGO's latest filing, up from $5.0 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $64.6 million in Q2 2023 to a low of $4.7 million in Q2 2024.
  • Average Total Debt over 5 years is $26.1 million, with a median of $25.0 million recorded in 2021.
  • Peak YoY movement for Total Debt: surged 138.74% in 2023, then crashed 92.68% in 2024.
  • A 5-year view of Total Debt shows it stood at $25.0 million in 2021, then soared by 138.22% to $59.6 million in 2022, then plummeted by 84.24% to $9.4 million in 2023, then crashed by 47.16% to $5.0 million in 2024, then rose by 0.81% to $5.0 million in 2025.
  • Per Business Quant, the three most recent readings for ANGO's Total Debt are $5.0 million (Q1 2025), $5.0 million (Q4 2024), and $4.8 million (Q3 2024).